Haematopoietic stem cell transplantation for autoimmune disorders: The American perspective

British Journal of Haematology

Volumn 126, Issue 5, 2004, Pages 637-649

  Popat, Uday ^a,b   Krance, Robert ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmune diseases; Bone marrow transplantation

Indexed keywords

ANTIINFECTIVE AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; THYMOCYTE ANTIBODY;

AUTOIMMUNE DISEASE; DISEASE MODEL; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UNITED STATES; WHOLE BODY RADIATION;

AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MODELS, ANIMAL; RANDOMIZED CONTROLLED TRIALS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; UNITED STATES;

EID: 4544350692     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05076.x     Document Type: Review

References (114)

1. Bach, J.F. & Chatenoud, L. (2001) Tolerance to islet autoantigens in type 1 diabetes. Annual Review of Immunology, 19, 131-161.
2. Beilhack, G.F., Scheffold, Y.C., Weissman, I.L., Taylor, C., Jerabek, L., Burge, M.J., Masek, M.A. & Shizuru, J.A. (2003) Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes, 52, 59-68.
3. van Bekkum, D.W. (1993) BMT in experimental autoimmune diseases. Bone Marrow Transplantation, 11, 183-187.
4. van Bekkum, D.W. (1999) Autologous stem cell transplantation for treatment of autoimmune diseases. Stem Cells, 17, 172-178.
5. van Bekkum, D.W. (2000) Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplantation, 25, 357-364.
6. van Bekkum, D.W. (2002) Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases. Journal of Leukocyte Biology, 72, 609-620.
7. van Bekkum, D.W., Bohre, E.P., Houben, P.F. & Knaan-Shanzer, S. (1989) Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America, 86, 10090-10094.
8. Bingham, S.J., Snowden, J., McGonagle, D., Richards, S., Isaacs, J., Morgan, G. & Emery, P. (2001) Autologous stem cell transplantation for rheumatoid arthritis-interim report of 6 patients. Journal of Rheumatology, 64(suppl.), 21-24.
9. Binks, M., Passweg, J.R., Furst, D., McSweeney, P., Sullivan, K., Besenthal, C., Finke, J., Peter, H.H., van Laar, J., Breedveld, F.C., Fibbe, W.E., Farge, D., Gluckman, E., Locatelli, F., Martini, A., van den, H.F., van de, P.L., Schattenberg, A.V., Arnold, R., Bacon, P.A., Emery, P., Espigado, I., Hertenstein, B., Hiepe, F., Kashyap, A., Kotter, I., Marmont, A., Martinez, A., Pascual, M.J., Gratwohl, A., Prentice, H.G., Black, C. & Tyndall, A. (2001) Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Annals of the Rheumatic Diseases, 60, 577-584.
10. Bjartmar, C., Wujek, J.R. & Trapp, B.D. (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. Journal of the Neurological Sciences, 206, 165-171.
11. Boumpas, D.T., Austin, H.A., III, Fessier, B.J., Balow, J.E., Klippel, J.H. & Lockshin, M.D. (1995a) Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Annals of Internal Medicine, 122, 940-950.
12. Boumpas, D.T., Fessler, B.J., Austin, H.A., Jr, Balow, J.E., Klippel, J.H. & Lockshin, M.D. (1995b) Systemic lupus erythematosus: emerging concepts. Part2: dermatologie and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Annals of Internal Medicine, 123, 42-53.
13. Breban, M., Dougados, M., Picard, F., Zompi, S., Marolleau, J.P., Bocaccio, C., Heshmati, F., Mezieres, M., Dreyfus, F. & Bouscary, D. (1999) Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis. Arthritis and Rheumatism, 42, 2275-2280.
14. Brodsky, R.A., Petri, M., Smith, B.D., Seifter, E.J., Spivak, J.L., Styler, M., Dang, C.V., Brodsky, I. & Jones, R.J. (1998) Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Annals of Internal Medicine, 129, 1031-1035.
15. Brunner, M., Greinix, H.T., Redlich, K., Knobl, P., Smolen, J., Leitner, G., Derfler, K., Graninger, W., Kalhs, P. & Machold, K. (2002) Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report. Arthritis and Rheumatism, 46, 1580-1584.
16. Bryan, C., Knight, C., Black, C.M. & Silman, A.J. (1999) Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis and Rheumatism, 42, 2660-2665.
17. Burt, R.K. & Kozak, T. (2003) Hematopoietic stem cell transplantation for multiple sclerosis: finding equipoise. Bone Marrow Transplantation, 32(suppl. 1), S45-S48.
18. Burt, R.K., Traynor, A.E., Cohen, B., Karlin, K.H., Davis, F.A., Stefoski, D., Terry, C., Lobeck, L., Russell, E.J., Goolsby, C., Rosen, S., Gordon, L.I., Keever-Taylor, C., Brush, M., Fishman, M. & Burns, W.H. (1998a) T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplantation, 21, 537-541.
19. Burt, R.K., Traynor, A.E., Pope, R., Schroeder, J., Cohen, B., Karlin, K.H., Lobeck, L., Goolsby, C., Rowlings, P., Davis, F.A., Stefoski, D., Terry, C., Keever-Taylor, C., Rosen, S., Vesole, D., Fishman, M., Brush, M., Mujias, S., Villa, M. & Burns, W.H. (1998b) Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood, 92, 3505-3514.
20. Burt, R.K., Georganas, C., Schroeder, J., Traynor, A., Stefka, J., Schuening, F., Graziano, F., Mineishi, S., Brush, M., Fishman, M., Welles, C., Rosen, S. & Pope, R. (1999) Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis and Rheumatism, 42, 2281-2285.
21. Burt, R.K., Fassas, A., Snowden, J., van Laar, J.M., Kozak, T., Wulffraat, N.M., Nash, R.A., Dunbar, C.E., Arnold, R., Prentice, G., Bingham, S., Marmont, A.M. & McSweeney, P.A. (2001) Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplantation, 28, 1-12.
22. Burt, R.K., Cohen, B.A., Russell, E., Spero, K., Joshi, A., Oyama, Y., Karpus, W.J., Luo, K., Jovanovic, B., Traynor, A., Karlin, K., Stefoski, D. & Burns, W.H. (2003a) Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood, 102, 2373-2378.
23. Burt, R.K., Oyama, Y., Traynor, A., Quigley, K., Brush, M., Rodriguez, J. & Barr, W.G. (2003b) Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring? Bone Marrow Transplantation, 32(suppl. 1), S65-S67.
24. Burt, R.K., Traynor, A., Oyama, Y. & Craig, R. (2003c) High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's disease. Blood, 101, 2064-2066.
25. Carreras, E., Saiz, A., Marin, P., Martinez, C., Rovira, M., Villamor, N., Aymerich, M., Lozano, M., Fernandez-Aviles, F., Urbano-Izpizua, A., Montserrat, E. & Graus, F. (2003) CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica, 88, 306-314.
26. Chatenoud, L., Salomon, B. & Bluestone, J.A. (2001) Suppressor T cells - they're back and critical for regulation of autoimmunity! Immunological Reviews, 182, 149-163.
27. Cines, D. & Blanchette, V. (2002) Immune thrombocytopenic purpura. New England Journal of Medicine, 346, 995-1008.
28. Coles, A.J., Wing, M.G., Molyneux, P., Paolillo, A., Davie, C.M., Hale, G., Miller, D., Waldmann, H. & Compston, A. (1999) Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Annals of Neurology, 46, 296-304.
29. Comi, G., Kappos, L., Clanet, M., Ebers, G., Fassas, A., Fazekas, F., Filippi, M., Hartung, H.P., Hertenstein, B., Karussis, D., Martino, G., Tyndall, A. & van der Meche, F.G. (2000) Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group. Journal of Neurology, 247, 376-382.
30. Craig, R.M., Traynor, A., Oyama, Y. & Burt, R.K. (2003) Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplantation, 32(suppl. 1), S57-S59.
31. Durez, P., Toungouz, M., Schandene, L., Lambermont, M. & Goldman, M. (1998) Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet, 352, 881.
32. Ermann, J. & Fathman, C.G. (2001) Autoimmune diseases: genes, bugs and failed regulation. Nature Immunology, 2, 759-761.
33. European Study Group on Interferon β-1b in Secondary Progressive MS (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS. Lancet, 352, 1491-1497.
34. Farge, D., Marolleau, J.P., Zohar, S., Marjanovic, Z., Cabane, J., Mounier, N., Hachulla, E., Philippe, P., Sibilia, J., Rabian, C., Chevret, S. & Gluckman, E. (2002) Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study. British Journal of Haematology, 119, 726-739.
35. Fassas, A., Anagnostopoulos, A., Kazis, A., Kapinas, K., Sakellari, I., Kimiskidis, V. & Tsompanakou, A. (1997) Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplantation, 20, 631-638.
36. Fassas, A., Anagnostopoulos, A., Kazis, A., Kapinas, K., Sakellari, I., Kimiskidis, V., Smias, C., Eleftheriadis, N. & Tsimourtou, V. (2000) Autologous stem cell transplantation in progressive multiple sclerosis - an interim analysis of efficacy. Journal of Clinical Immunology, 20, 24-30.
37. Fassas, A., Passweg, J.R., Anagnostopoulos, A., Kazis, A., Kozak, T., Havrdova, E., Carreras, E., Graus, F., Kashyap, A., Openshaw, H., Schipperus, M., Deconinck, E., Mancardi, G., Marmont, A., Hansz, J., Rabusin, M., Zuazu Nagore, F.J., Besalduch, J., Dentamaro, T., Fouillard, L., Hertenstein, B., LaNasa, G., Musso, M., Papineschi, F., Rowe, J.M., Saccardi, R., Steck, A., Kappos, L., Gratwohl, A., Tyndall, A., Samijn, J. & Samign, J. (2002) Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. Journal of Neurology, 249, 1088-1097.
38. Fouillard, L., Gorin, N.C., Laporte, J.P., Leon, A., Brantus, J.F. & Miossec, P. (1999) Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus, 8, 320-323.
39. Furst, D.E. & Clements, P.J. (1997) Hypothesis for the pathogenesis of systemic sclerosis. Journal of Rheumatology, 48(suppl.), 53-57.
40. van Gelder, M. & van Bekkum, D.W. (1996) Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplantation, 18, 1029-1034.
41. Gladman, D.D. (1997) Prognostic subsets and mortality in systemic lupus erythematosus. In: Dubois' Lupus Erythematosus (ed. by D.J. Wallace & B. Hann), pp. 1213-1227.
42. Good, R.A. & Ikehara, S. (1997) Preclinical investigations that subserve efforts to employ bone marrow transplantation for rheumatoid or autoimmune diseases. Journal of Rheumatology, 48(suppl.), 5-12.
43. Huhn, R.D., Fogarty, P.F., Nakamura, R., Read, E.J., Leitman, S.F., Rick, M.E., Kimball, J., Greene, A., Hansmann, K., Gratwohl, A., Young, N., Barrett, A.J. & Dunbar, C.E. (2003) High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood, 101, 71-77.
44. Ikehara, S. (1998) Bone marrow transplantation for autoimmune diseases. Acta Haematologica, 99, 116-132.
45. Ikehara, S. (2001) Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Experimental Hematology, 29, 661-669.
46. Ikehara, S., Good, R.A., Nakamura, T., Sekita, K., Inoue, S., Oo, M.M., Muso, E., Ogawa, K. & Hamashima, Y. (1985a) Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proceedings of the National Academy of Sciences of the United States of America, 82, 2483-2487.
47. Ikehara, S., Ohtsuki, H., Good, R.A., Asamoto, H., Nakamura, T., Sekita, K., Muso, E., Tochino, Y., Ida, T. & Kuzuya, H. (1985b) Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America, 82, 7743-7747.
48. Ikehara, S., Yasumizu, R., Inaba, M., Izui, S., Hayakawa, K., Sekita, K., Toki, J., Sugiura, K., Iwai, H. & Nakamura, T. (1989) Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America, 86, 3306-3310.
49. Ikehara, S., Kawamura, M., Takao, F., Inaba, M., Yasumizu, R., Than, S., Hisha, H., Sugiura, K., Koide, Y. & Yoshida, T.O. (1990) Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 87, 8341-8344.
50. Ishida, T., Inaba, M., Hisha, H., Sugiura, K., Adachi, Y., Nagata, N., Ogawa, R., Good, R.A. & Ikehara, S. (1994) Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. Journal of Immunology, 152, 3119-3127.
51. Kondo, M., Wagers, A.J., Manz, M.G., Prohaska, S.S., Scherer, D.C., Beilhack, G.F., Shizuru, J.A. & Weissman, I.L. (2003) Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annual Review of Immunology, 21, 759-806.
52. Kozak, T., Havrdova, E., Pit'ha, J., Gregora, E., Pytlik, R., Maaloufova, J., Mareckova, H., Kobylka, P. & Vodvarkova, S. (2000) High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplantation, 25, 525-531.
53. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33, 1444-1452.
54. van Laar, J.M. & Tyndall, A. (2003) Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Cancer Control, 10, 57-65.
55. Lee, D.M. & Weinblatt, M.E. (2001) Rheumatoid arthritis. Lancet, 358, 903-911.
56. Li, H., Kaufman, C.L., Boggs, S.S., Johnson, P.C., Patrene, K.D. & Ildstad, S.T. (1996) Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. Journal of Immunology, 156, 380-388.
57. Lipsky, P.E. (2001) Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nature Immunology, 2, 764-766.
58. Mancardi, G.L., Saccardi, R., Filippi, M., Gualandi, F., Murialdo, A., Inglese, M., Marrosu, M.G., Meucci, G., Massacesi, L., Lugaresi, A., Pagliai, F., Sormani, M.P., Sardanelli, F. & Marmont, A. (2001) Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology, 57, 62-68.
59. Marmont, A.M., van Lint, M.T., Gualandi, F. & Bacigalupo, A. (1997) Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus, 6, 545-548.
60. McGonagle, D., Rawstron, A., Richards, S., Isaacs, J., Bird, H., Jack, A., Morgan, G. & Emery, P. (1997) A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis. Arthritis and Rheumatism, 40, 1838-1842.
61. McSweeney, P.A., Nash, R.A., Sullivan, K.M., Storek, J., Crofford, L.J., Dansey, R., Mayes, M.D., McDonagh, K.T., Nelson, J.L., Gooley, T.A., Holmberg, L.A., Chen, C.S., Wener, M.H., Ryan, K., Sunderhaus, J., Russell, K., Rambharose, J., Storb, R. & Furst, D.E. (2002) High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood, 100, 1602-1610.
62. Mills, J.A. (1994) Systemic lupus erythematosus. New England Journal of Medicine, 330, 1871-1879.
63. Miyashima, S., Nagata, N., Nakagawa, T., Hosaka, N., Takeuchi, K., Ogawa, R. & Ikehara, S. (1996) Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. Journal of Immunology, 156, 79-84.
64. Moore, J., Brooks, P., Milliken, S., Biggs, J., Ma, D., Handel, M., Cannell, P., Will, R., Rule, S., Joske, D., Langlands, B., Taylor, K., O'Callaghan, J., Szer, J., Wicks, I., McColl, G., Passeullo, F. & Snowden, J. (2002) A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis and Rheumatism, 46, 2301-2309.
65. Moore, J.J., Snowden, J., Pavletic, S., Barr, W. & Burt, R. (2003) Hematopoietic stem cell transplantation for severe rheumatoid arthritis. Bone Marrow Transplantation, 32(suppl. 1), S53-S56.
66. Morahan, G. & Morel, L. (2002) Genetics of autoimmune diseases in humans and in animal models. Current Opinion in Immunology, 14, 803-811.
67. Morton, J.I. & Siegel, B.V. (1974) Transplantation of autoimmune potential. I. Development of antinudear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proceedings of the National Academy of Sciences of the United States of America, 71, 2162-2165.
68. Musso, M., Porretto, F., Crescimanno, A., Bondi, F., Polizzi, V., Scalone, R. & Mariani, G. (1998) Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus, 7, 492-494.
69. Musso, M., Porretto, F., Crescimanno, A., Bondi, F., Polizzi, V. & Scalone, R. (2001) Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. American Journal of Hematology, 66, 75-79.
70. Nash, R.A. (2003) Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens. Bone Marrow Transplantation, 32(suppl. 1), S77-S80.
71. Nash, R.A., Bowen, J.D., McSweeney, P.A., Pavletic, S.Z., Maravilla, K.R., Park, M.S., Storek, J., Sullivan, K.M., Al Omaishi, J., Corboy, J.R., Dipersio, J., Georges, G.E., Gooley, T.A., Holmberg, L.A., LeMaistre, C.F., Ryan, K., Openshaw, H., Sunderhaus, J., Storb, R., Zunt, J. & Kraft, G.H. (2003a) High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood, 102, 2364-2372.
72. Nash, R.A., Dansey, R., Storek, J., Georges, G.E., Bowen, J.D., Holmberg, L.A., Kraft, G.H., Mayes, M.D., McDonagh, K.T., Chen, C.S., Dipersio, J., LeMaistre, C.F., Pavletic, S., Sullivan, K.M., Sunderhaus, J., Furst, D.E. & McSweeney, P.A. (2003b) Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biology of Blood and Marrow Transplantation, 9, 583-591.
73. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. & Weinshenker, B.C. (2000) Multiple sclerosis. New England Journal of Medicine, 343, 938-952.
74. Openshaw, H., Stuve, O., Antel, J.P., Nash, R., Lund, B.T., Weiner, L.P., Kashyap, A., McSweeney, P. & Forman, S. (2000a) Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology, 54, 2147-2150.
75. Openshaw, H., Lund, B.T., Kashyap, A., Atkinson, R., Sniecinski, I., Weiner, L.P. & Forman, S. (2000b) Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biology of Blood and Marrow Transplantation, 6, 563-575.
76. Oyama, Y., Cohen, B., Traynor, A., Brush, M., Rodriguez, J. & Burt, R.K. (2002) Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation, 29, 81-85.
77. Oyama, Y., Traynor, A.E., Barr, W. & Burt, R.K. (2003) Allogeneic stem cell transplantation for autoimmune diseases: non-myeloablative conditioning regimens. Bone Marrow Transplantation, 32(suppl. 1), S81-S83.
78. Passweg, J.R., Rabusin, M., Musso, M., Beguin, Y., Cesaro, S., Ehninger, G., Espigado, I., Iriondo, A., Jost, L., Koza, V., Lenhoff, S., Lisukov, I., Locatelli, F., Marmont, A., Philippe, P., Pilatrino, C., Quartier, P., Stary, J., Veys, P., Vormoor, J., Wahlin, A., Zintl, F., Bocelli-Tyndall, C., Tyndall, A., Gratwohl, A., for the Autoimmune Disease Working Party of the EBMT, Jun 2004 (2004) Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. British Journal of Haematology, 125, 749-755.
79. Pavletic, S.Z., Odell, J.R., Pirruccello, S.J., Ursick, M.M., Haire, C.E., Sharp, J.G., Kessinger, A. & Klassen, L.W. (2001a) Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience. Journal of Rheumatology, 64(suppl.), 13-20.
80. Pavletic, S.Z., Klassen, L.W., Pope, R., O'Dell, J.R., Traynor, A.E., Haire, C.E., Graziano, F., Oyama, Y., Barr, W. & Burt, R.K. (2001b) Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis. Journal of Rheumatology, 64(suppl.), 28-31.
81. Petri, M., Jones, R.J. & Brodsky, R.A. (2003) High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis and Rheumatism, 48, 166-173.
82. Pincus, T., Brooks, R.H. & Callahan, L.F. (1994) Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Annals of Internal Medicine, 120, 26-34.
83. Quartier, P., Prieur, A.M. & Fischer, A. (1999) Haemopoietic stem-cell transplantation for juvenile chronic arthritis. Lancet, 353, 1885-1886.
84. Rosen, O., Thiel, A., Massenkeil, G., Hiepe, F., Haupl, T., Radtke, H., Burmester, G.R., Gromnica-Ihle, E., Radbruch, A. & Arnold, R. (2000) Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Research, 2, 327-336.
85. Rosen, O., Massenkeil, G., Hiepe, F., Pest, S., Hauptmann, S., Radtke, H., Burmester, G., Thiel, A., Radbruch, A., Heymer, B. & Arnold, R. (2001) Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplantation, 27, 657-658.
86. Runmarker, B. & Andersen, O. (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain, 116, 117-134.
87. Sakaguchi, S. (2000) Animal models of autoimmunity and their relevance to human diseases. Current Opinion in Immunology, 12, 684-690.
88. Sardina, E.E., Sugiura, K., Ikehara, S. & Good, R.A. (1991) Transplantation of wheat germ agglutinin-positive hematopoietic cells to prevent or induce systemic autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America, 88, 3218-3222.
89. Snowden, J.A., Biggs, J.C., Milliken, S.T., Fuller, A., Staniforth, D., Passuello, F., Renwick, J. & Brooks, P.M. (1998) A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplantation, 22, 1035-1041.
90. Snowden, J.A., Biggs, J.C., Milliken, S.T., Fuller, A. & Brooks, P.M. (1999) A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis and Rheumatism, 42, 2286-2292.
91. Snowden, J., Moore, J. & Passweg, J. (2001) Autologous stem cell transplantation for rheumatoid arthritis. Blood, 98, 860a.
92. Steen, V.D. & Medsger, T.A., Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis and Rheumatism, 43, 2437-2444.
93. Steptoe, R.J., Ritchie, J.M. & Harrison, L.C. (2003) Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. Journal of Clinical Investigation, 111, 1357-1363.
94. Sun, W., Popat, U., Hutton, G., Zang, Y.C., Krance, R., Carrum, G., Land, G.A., Heslop, H., Brenner, M. & Zhang, J.Z. (2004) Characteristics of T cell receptor repertoire and myelin-reactive T cells reconstituted from autologous hematopoietic stem cell grafts in multiple sclerosis. Brain, 127, 996-1008.
95. Swanborg, R.H. (2001) Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunological Reviews, 184, 129-135.
96. Taneja, V. & David, C.S. (2001) Lessons from animal models for human autoimmune diseases. Nature Immunology, 2, 781-784.
97. Traynor, A.E., Schroeder, J., Rosa, R.M., Cheng, D., Stefka, J., Mujais, S., Baker, S. & Burt, R.K. (2000) Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet, 356, 701-707.
98. Traynor, A.E., Barr, W.G., Rosa, R.M., Rodriguez, J., Oyama, Y., Baker, S., Brush, M. & Burt, R.K. (2002) Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis and Rheumatism, 46, 2917-2923.
99. Trysberg, E., Lindgren, I. & Tarkowski, A. (2000) Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus. Annals of the Rheumatic Diseases, 59, 236-238.
100. Tyndall, A., Passweg, J. & Gratwohl, A. (2001) Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000. Annals of the Rheumatic Diseases, 60, 702-707.
101. Verburg, R.J., Kruize, A.A., van den Hoogen, F.H., Fibbe, W.E., Petersen, E.J., Preijers, F., Sont, J.K., Barge, R.M., Bijlsma, J.W., van de Putte, L.B., Breedveld, F.C. & van Laar, J.M. (2001a) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis and Rheumatism, 44, 754-760.
102. Verburg, R.J., Sont, J.K., Vliet Vlieland, T.P., Landewe, R.B., Boers, M., Kievit, J. & van Laar, J.M. (2001b) High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis. Journal of Rheumatology, 28, 719-727.
103. Vigouroux, S., Yvon, E., Biagi, E. & Brenner, M.K. (2004) Antigen-induced regulatory T cells. Blood [Epub ahead of print.] PMID: 15026316 DOI 10.1182/blood-2004-01-0182.
104. Wakeland, E.K., Liu, K., Graham, R.R. & Behrens, T.W. (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity, 15, 397-408.
105. Wandstrat, A.W. & Wakeland, E. (2001) The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nature Immunology, 2, 802-809.
106. Weinshenker, B.G. (1998) The natural history of multiple sclerosis: update 1998. Seminars in Neurology, 18, 301-307.
107. Weinshenker, B.G., Bass, B., Rice, G.P., Noseworthy, J., Carriere, W., Baskerville, J. & Ebers, G.C. (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain, 112, 133-146.
108. Weinshenker, B.G., Issa, M. & Baskerville, J. (1996) Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology, 46, 1613-1619.
109. Wolfe, F., Mitchell, D.M., Sibley, J.T., Fries, J.F., Bloch, D.A., Williams, C.A., Spitz, P.W., Haga, M., Kleinheksel, S.M. & Cathey, M.A. (1994) The mortality of rheumatoid arthritis. Arthritis and Rheumatism, 37, 481-494.
110. Wucherpfennig, K.W. & Eisenbarth, G.S. (2001) Type 1 diabetes. Nature Immunology, 2, 767-768.
111. Wulffraat, N., van Royen, A., Bierings, M., Vossen, J. & Kuis, W. (1999) Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet, 353, 550-553.
112. Wulffraat, N.M., Sanders, E.A., Kamphuis, S.S., Rijkers, G.T., Kuis, W., Lilien, M. & Slaper-Cortenbach, I.C. (2001) Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis and Rheumatism, 44, 728-731.
113. Wulffraat, N.M., Brinkman, D., Ferster, A., Opperman, J., ten Cate, R., Wedderburn, L., Foster, H., Abinun, M., Prieur, A.M., Horneff, G., Zintl, F., De, K.I. & Kuis, W. (2003) Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplantation, 32(suppl. 1), S61-S64.
114. Yasumizu, R., Sugiura, K., Iwai, H., Inaba, M., Makino, S., Ida, T., Imura, H., Hamashima, Y., Good, R.A. & Ikehara, S. (1987) Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proceedings of the National Academy of Sciences of the United States of America, 84, 6555-6557.